Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sanders

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Assay and Drug Development Technologies|May 5, 2007
An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidatesDieter M Drexler, James V Belcastro, Kenneth E Dickinson, et al.
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
British Journal of Pain|September 14, 2020
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above targetJatinder Bisla, Gareth Ambler, Bernhard Frank, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Assay and Drug Development Technologies|May 5, 2007
An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidatesDieter M Drexler, James V Belcastro, Kenneth E Dickinson, et al.
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
British Journal of Pain|September 14, 2020
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above targetJatinder Bisla, Gareth Ambler, Bernhard Frank, et al.
Pageof 7